Ahmed Hinda J, Johansson Catharina, Svensson Liselott A, Ahlman Karin, Verdrengh Margareta, Lagergård Teresa
Department of Medical Microbiology and Immunology, University of Göteborg, S-413 46 Göteborg, Sweden.
Infect Immun. 2002 Feb;70(2):899-908. doi: 10.1128/IAI.70.2.899-908.2002.
We investigated the phagocytosis of Haemophilus ducreyi both in vitro and in vivo. Human granulocyte and monocyte phagocytosis of opsonized and nonopsonized, fluorescence-labeled H. ducreyi was assessed by flow cytometry. Both Escherichia coli and noncapsulated H. influenzae were included as controls. The maximal percentage of granulocytes taken up by H. ducreyi was 35% after 90 min. In contrast, 95% of H. influenzae bacteria were phagocytosed by granulocytes after 30 min. These results indicated that H. ducreyi phagocytosis was slow and inefficient. Bacterial opsonization by using specific antibodies increased the percentage of granulocytes phagocytosing H. ducreyi from 24 to 49%. The nonphagocytosed bacteria were completely resistant to phagocytosis even when reexposed to granulocytes, indicating that the H. ducreyi culture comprised a mixture of phenotypes. The intracellular survival of H. ducreyi in granulocytes, in monocytes/macrophages, and in a monocyte cell line (THP-1) was quantified after application of gentamicin treatment to kill extracellular bacteria. H. ducreyi survival within phagocytes was poor; approximately 11 and <0.1% of the added bacteria survived intracellularly after 2 and 20 h of incubation, respectively, while no intracellular H. influenzae bacteria were recovered after 2 h of incubation with phagocytes. The role of phagocytes in the development of skin lesions due to H. ducreyi was also studied in vivo. Mice that were depleted of granulocytes and/or monocytes and SCID mice, which lacked T and B cells, were injected intradermally with approximately 10(6) CFU of H. ducreyi. Within 4 days of inoculation, the granulocyte-depleted mice developed lesions that persisted throughout the experimental period. This result reinforces the importance of granulocytes in the early innate defense against H. ducreyi infection. In conclusion, H. ducreyi is insufficiently phagocytosed to achieve complete eradication of the bacteria. Indeed, H. ducreyi has the ability to survive intracellularly for short periods within phagocytic cells in vitro. Since granulocytes play a major role in the innate defense against H. ducreyi infection in vivo, bacterial resistance to phagocytosis probably plays a crucial role in the pathogenesis of chancroid.
我们对杜克雷嗜血杆菌在体外和体内的吞噬作用进行了研究。通过流式细胞术评估了人粒细胞和单核细胞对经调理素处理和未经调理素处理的荧光标记杜克雷嗜血杆菌的吞噬作用。将大肠杆菌和无荚膜流感嗜血杆菌作为对照。90分钟后,杜克雷嗜血杆菌摄取的粒细胞最大百分比为35%。相比之下,30分钟后,95%的流感嗜血杆菌被粒细胞吞噬。这些结果表明,杜克雷嗜血杆菌的吞噬作用缓慢且效率低下。使用特异性抗体进行细菌调理素化处理后,吞噬杜克雷嗜血杆菌的粒细胞百分比从24%增加到了49%。即使再次暴露于粒细胞,未被吞噬的细菌对吞噬作用仍具有完全抗性,这表明杜克雷嗜血杆菌培养物包含多种表型的混合物。在用庆大霉素处理以杀死细胞外细菌后,对杜克雷嗜血杆菌在粒细胞、单核细胞/巨噬细胞和单核细胞系(THP-1)中的细胞内存活情况进行了定量分析。杜克雷嗜血杆菌在吞噬细胞内的存活情况较差;分别在孵育2小时和20小时后,添加细菌中约11%和<0.1%在细胞内存活,而与吞噬细胞孵育2小时后未回收细胞内流感嗜血杆菌。还在体内研究了吞噬细胞在杜克雷嗜血杆菌所致皮肤病变发展中的作用。对粒细胞和/或单核细胞耗竭的小鼠以及缺乏T细胞和B细胞的SCID小鼠皮内注射约10(6)CFU的杜克雷嗜血杆菌。接种后4天内,粒细胞耗竭的小鼠出现病变,并在整个实验期间持续存在。这一结果强化了粒细胞在针对杜克雷嗜血杆菌感染的早期固有防御中的重要性。总之,杜克雷嗜血杆菌的吞噬作用不足以实现对细菌的完全根除。实际上,杜克雷嗜血杆菌在体外能够在吞噬细胞内短期存活。由于粒细胞在体内针对杜克雷嗜血杆菌感染的固有防御中起主要作用,细菌对吞噬作用的抗性可能在软下疳的发病机制中起关键作用。